Organization

Montpellier University Hospital Center

3 abstracts

Abstract
Impact of bridging therapy (BT) on lisocabtagene maraleucel (liso-cel) treatment in patients (pt) with R/R follicular lymphoma (FL).
Org: Universität zu Köln, Karolinska Institutet and University Hospital, Montpellier University Hospital Center, Groupe de Recherche sur les formes Injectables et les Technologies Associées,
Abstract
Ixazomib and daratumumab without dexamethasone (I-Dara) in elderly frail patients with RRMM: Results of the multicenter phase 2 study (IFM 2018-02) of the Intergroupe Francophone du Myélome (IFM).
Org: University Hospital of Nantes, France, Centre Hospitalier Universitaire de Poitiers, CHU Grenoble Alpes, Lille University Hospital, APHP Hôpital Avicenne,
Abstract
Are eular rheumatoid arthritis (RA) management recommendations applicable at the country level? similarities and differences with the recent french ra management recommendations
Org: Nîmes University hospital, EA2415, Montpellier University, Nîmes, Montpellier University Hospital Center, Nîmes SFR Recommendations Working Group, Paris, France,